Equally important, the high expression of LINC01198 is associated with a high score of CD8, IL-2, IL-8, and IL-12 immune signatures and improved OS in BC patients, indicating that LINC01198 is a promoter of IFN-related antitumoral immune response (67). Here, CD8A is linked to breast cancer.